万维提示：
1、投稿方式：在线投稿。
2、期刊网址：
https://www.journals.elsevier.com/the-ocular-surface/
3、投稿网址：
https://www.editorialmanager.com/THEOCULARSURFACE/default.aspx
4、官网邮箱：adjalili@uic.edu（主编）
ocularsurface@stellarmed.com（总编）
5、期刊刊期：季刊，逢季首月出版。
2021年5月31日星期一
投稿须知【官网信息】
Guide for Authors
A peer-reviewed quarterly journal, The Ocular Surface (TOS) features concise, state-of-the-art, referenced review articles to elucidate the vast body of findings in this rapidly evolving field. Its purview ranges from molecular biology to surgery, encompassing lacrimal, lid, and ocular surface physiology, pathology, pharmacology, and medical/surgical therapeutic interventions. TOS also publishes select high impact original research reports and articles describing innovative techniques and technology. Descriptions of desired content and requirements for articles are described below under the section headings: Review Articles; High Impact Original Research Reports; Innovative Techniques and Technology; Research Correspondence; and Special Issue Articles.. All manuscripts undergo peer review by two or more reviewers. Authors are asked to revise their manuscripts, addressing all the reviewers' suggestions or explaining their reasons for declining to do so.
Submission
Manuscripts must be submitted through Editorial Manager: https://www.editorialmanager.com/THEOCULARSURFACE/default.aspx
Submission checklist
You can use this list to carry out a final check of your submission before you send it to the journal for review. Please check the relevant section in this Guide for Authors for more details.
Ensure that the following items are present:
One author has been designated as the corresponding author with contact details:
E-mail address
Full postal address
All necessary files have been uploaded:
Manuscript:
Include keywords
Ensure that the manuscript file includes a disclosure section just before the references even if the authors have no conflicts to disclose
All figures (include relevant captions)
All tables (including titles, description, footnotes)
Ensure all figure and table citations in the text match the files provided
Graphical Abstracts / Highlights files(where applicable)
Supplemental files where applicable)
Further considerations
Manuscript has been 'spell checked' and 'grammar checked'
All references mentioned in the Reference List are cited in the text, and vice versa
Permission has been obtained for use of copyrighted material from other sources (including the Internet)
Journal policies detailed in this guide have been reviewed
Referee suggestions and contact details provided, based on journal requirements
While submitting revision, make sure that you submit: 1. The Revised Manuscript with track changes under the file type "Revised Manuscript with Changes Marked; 2. A clean version of the Revised Manuscript under the file type "Manuscript File"; 3. Response to reviewers in a separate file.
For further information, visit our Support Center.
Guidelines for Writing Articles
Review Articles
Most reviews are written at the invitation of the editors, but independent proposals of articles are welcomed. To propose a review, please email a brief description of the intended review to Editor-in-Chief Ali Djalilian, MD (adjalili@uic.edu) and Managing Editor David Newcombe (ocularsurface@stellarmed.com). If the editors consider the topic to be appropriate, you will be asked to submit a detailed outline and tentative bibliography for peer review.
Guidelines
For these comprehensive reviews we require at least one author (senior author) to have at least 10 years of experience in that particular space. We would like these reviews to go beyond just summarizing what is known and published in the literature and instead to synthesize all the existing information to propose new ideas/paradigms, identify and try to resolve controversies, identify the major gaps in knowledge, what are the technical challenges, what is the outlook for the future
Reviews should follow a topic-based outline, labeled with headings and subheadings [I,A,1,a, (1), (a)]. A TOS review should not be a general overview of a topic, but rather an in-depth, literature-based, critical review that emphasizes areas of new information, controversies, etc. The authors' own findings may be cited in the context of findings published in the literature, but original work should not be the focus of the review. The readers will have various levels of understanding about specific topic areas, so it is important for authors to provide the background, definitions, and explanations necessary to enhance understanding. Illustrative figures and diagrams are very helpful.Format
1. Abstract
Please submit a narrative abstract.
2. Length of Text
Appropriate length is usually about 10-14 printed pages (equivalent to about 24-34 double-spaced manuscript pages, including references, figures and tables).
3. Disclosure
In a paragraph before the reference section, authors must disclose any potential conflicts of interest. If no potential conflicts exist, that must be stated.
4. Method of Literature Search
The review manuscript should state the method of literature selection, specifying search words and data bases used, as well as the date of search; number of articles retrieved; criteria for selecting articles for inclusion in review; criteria for excluding articles.
5. References
A review article should not cite all publications relevant to the topic of the article; rather, the references should be selected according to their importance and usefulness in clarifying, documenting, and providing historical background. Multiple similar references to document a statement are usually not needed. The appropriate number of references varies according to the length of the article and the complexity of the topic. The number of references in a 12-14 page review article (20-30 double-spaced typed pages of text) should seldom exceed 150, although there may be exceptions to this guideline. Authors are encouraged to request advice from the editors if it seems that more references are appropriate.
High Impact Original Research Reports
The goal of including original research articles in TOS is to provide rapid, peer-reviewed publication of high-quality, high-impact information that holds promise of significantly advancing the understanding of the ocular surface. The work should present new conceptual frameworks or novel research findings that challenge or enhance our current approach to clinical practice or research.
Guidelines
To this end, the research must:
1. Be original research of the author that is conducted with sound scientific method
2. Provide new information that answers a specific question regarding ocular surface health or disease
3. Provide new, mechanistically based information
4. Be presented according to the author guidelines and format listed below
5. Be performed according to tenets of good laboratory and clinical practice:
a. If involving laboratory animals, the work should conform to the ARVO guidelines for humane use of such animals;
b. If involving human subjects, the work should conform to the Declaration of Helsinki and provide for informed consent in an IRB approved protocol;
c. If involving a clinical trial, should be registered with a clinical trial registry
6. Be presented in a clear, logical manner with sufficient detail to be reproducible by other researchers
7. Present rationale and statistical analysis of data support conclusions
Format
1. Title Page: (As above under "Manuscript Preparation")
2. Structured abstract: A structured abstract of fewer than 250 words is required for original research articles and should be arranged under the following headings: Purpose, Methods, Results, and Conclusions. Abbreviations should be defined at first mention, Do not include references. The abstract must be included as part of the main manuscript file.
3. Text: The Ocular Surface recommends a 3,500 or fewer word count, excluding title page, legends, and references. The text should be double-spaced.
In a brief Introduction, provide the research rationale and objectives without extensively reviewing the literature. In the Methods section, describe the experimental design, subjects used, and procedures followed. Previously published procedures should be identified by reference only. Provide sufficient detail to enable others to duplicate the research. Use standard chemical or nonproprietary pharmaceutical nomenclature. In parentheses, identify specific sources by brand name, company, city, and state or country. A description of the statistical analysis techniques should be included. If human subjects were involved in the investigation, the Methods section must confirm that: (1) the research followed the tenets of the Declaration of Helsinki; (2) informed consent was obtained from the subjects after explanation of the nature and possible consequences of the study; and (3) where applicable, the research was approved by the institutional human experimentation committee or institutional review board (IRB).
If experimental animals were used in the investigation, the Methods section must confirm adherence to the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research and, where applicable, approval by the appropriate animal research review board.
Present the Results with a minimum of discussion. Cite all tables and figures in numerical order. Limit the Discussion to statistically significant data and their limitations. Do not reiterate results.
4. Acknowledgments: Acknowledgments should be written in the third person and be limited to colleagues and research assistants. Acknowledgments are not meant to recognize appreciation for personal or manuscript production support. Including dedications to individuals or groups is not allowed.
5. Disclosure/Conflict of Interest Statement: In a paragraph before the reference section, authors must disclose any potential conflicts of interest. If no potential conflicts exist, that must be stated.
6. References (as described under "Manuscript Preparation")
Innovative Techniques and Technology
Evolving technologies and techniques in both the basic and clinical arenas often do not have sufficient published peer-reviewed data to permit a comprehensive review for inclusion in the basic science, clinical research, or clinical practice sections of The Ocular Surface. Nonetheless, there is a value to both researcher and clinician in being aware of the potential applications and pitfalls of such new technology. In order to inform our readership of evolving technologies and techniques, publication of articles describing such options with adequate peer review is appropriate.
Appropriate length for ITT articles is usually about 6-8 printed pages, including figures and references (equivalent of about 9-14 double-spaced typed pages).
Guidelines
1. Technologies or techniques should provide a significant insight or advance in the basic or clinical investigation or treatment of the ocular surface.
2. Manuscripts should critically describe outcome data, not just a proposed method or technique.
3. Figures or diagrams to illustrate the application or interpretation of the technique should be included.
4. Appropriate references to support conclusions and claims should be provided, even if the number of such references is limited.
5. Commercial bias must be avoided, and the value of the technology/technique must be factually supported, not speculative.
6. The author must fully disclose all proprietary and financial interests or support.
7. An attempt will be made to include such articles in issues that have a corresponding related topic in any review of the three major sections of the journal.
Format
1. Narrative abstract
2. Brief introduction describing purpose of the procedure, other procedures used for the same purpose, and advantages of (need for) the new procedure.
3. Description of the technique, including theoretical basis and steps in performing (including figures and diagrams).4. Outcome data
5. Summary/Conclusion
6. Disclosure: In a paragraph before the reference section, authors must disclose any potential conflicts of interest. If no potential conflicts exist, that must be stated.
7. References (as described under "Manuscript Preparation")
Research Correspondence
This publication is type for novel findings that are more limited in scope. The format is similar to an editorial or a letter to editor with no abstract or subheadings in the text. There is a strict 1200 word limit as well as a limit of 7 references. Only one Figure or Table is permitted (not both). Disclosure is required in a paragraph before the reference section. Authors must disclose any potential conflicts of interest. If no potential conflicts exist, that must be stated.
Special Issue Articles
These are invited articles that pertain to a central theme. e.g. meibomian gland, infection. The journal creates online collections for each of the themes. Special Issue Articles should follow the same format as High Impact Original Research Reports
Ethics in publishing
Please see our information pages on Ethics in publishing and Ethical guidelines for journal publication.
Studies in humans and animals
If the work involves the use of human subjects, the author should ensure that the work described has been carried out in accordance with The Code of Ethics of the World Medical Association (Declaration of Helsinki) for experiments involving humans. The manuscript should be in line with the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals and aim for the inclusion of representative human populations (sex, age and ethnicity) as per those recommendations. The terms sex and gender should be used correctly.
Authors should include a statement in the manuscript that informed consent was obtained for experimentation with human subjects. The privacy rights of human subjects must always be observed.
All animal experiments should comply with the ARRIVE guidelines and should be carried out in accordance with the U.K. Animals (Scientific Procedures) Act, 1986 and associated guidelines, EU Directive 2010/63/EU for animal experiments, or the National Institutes of Health guide for the care and use of Laboratory animals (NIH Publications No. 8023, revised 1978) and the authors should clearly indicate in the manuscript that such guidelines have been followed. The sex of animals must be indicated, and where appropriate, the influence (or association) of sex on the results of the study.
Informed consent and patient details
Studies on patients or volunteers require ethics committee approval and informed consent, which should be documented in the paper. Appropriate consents, permissions and releases must be obtained where an author wishes to include case details or other personal information or images of patients and any other individuals in an Elsevier publication. Written consents must be retained by the author but copies should not be provided to the journal. Only if specifically requested by the journal in exceptional circumstances (for example if a legal issue arises) the author must provide copies of the consents or evidence that such consents have been obtained. For more information, please review the Elsevier Policy on the Use of Images or Personal Information of Patients or other Individuals. Unless you have written permission from the patient (or, where applicable, the next of kin), the personal details of any patient included in any part of the article and in any supplementary materials (including all illustrations and videos) must be removed before submission.
Declaration of interest
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. Examples of potential competing interests include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. Authors must disclose any interests in two places: 1. A summary declaration of interest statement in the title page file (if double anonymized) or the manuscript file (if single anonymized). If there are no interests to declare then please state this: 'Declarations of interest: none'. 2. Detailed disclosures as part of a separate Declaration of Interest form, which forms part of the journal's official records. It is important for potential interests to be declared in both places and that the information matches. More information.
Submission declaration and verification
Submission of an article implies that the work described has not been published previously (except in the form of an abstract, a published lecture or academic thesis, see 'Multiple, redundant or concurrent publication' for more information), that it is not under consideration for publication elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published elsewhere in the same form, in English or in any other language, including electronically without the written consent of the copyright-holder. To verify originality, your article may be checked by the originality detection service Crossref Similarity Check.
Preprints
Please note that preprints can be shared anywhere at any time, in line with Elsevier's sharing policy. Sharing your preprints e.g. on a preprint server will not count as prior publication (see 'Multiple, redundant or concurrent publication' for more information).
Use of inclusive language
Inclusive language acknowledges diversity, conveys respect to all people, is sensitive to differences, and promotes equal opportunities. Content should make no assumptions about the beliefs or commitments of any reader; contain nothing which might imply that one individual is superior to another on the grounds of age, gender, race, ethnicity, culture, sexual orientation, disability or health condition; and use inclusive language throughout. Authors should ensure that writing is free from bias, stereotypes, slang, reference to dominant culture and/or cultural assumptions. We advise to seek gender neutrality by using plural nouns ("clinicians, patients/clients") as default/wherever possible to avoid using "he, she," or "he/she." We recommend avoiding the use of descriptors that refer to personal attributes such as age, gender, race, ethnicity, culture, sexual orientation, disability or health condition unless they are relevant and valid. These guidelines are meant as a point of reference to help identify appropriate language but are by no means exhaustive or definitive.
Changes to authorship
Authors are expected to consider carefully the list and order of authors before submitting their manuscript and provide the definitive list of authors at the time of the original submission. Any addition, deletion or rearrangement of author names in the authorship list should be made only before the manuscript has been accepted and only if approved by the journal Editor. To request such a change, the Editor must receive the following from the corresponding author: (a) the reason for the change in author list and (b) written confirmation (e-mail, letter) from all authors that they agree with the addition, removal or rearrangement. In the case of addition or removal of authors, this includes confirmation from the author being added or removed.
Only in exceptional circumstances will the Editor consider the addition, deletion or rearrangement of authors after the manuscript has been accepted. While the Editor considers the request, publication of the manuscript will be suspended. If the manuscript has already been published in an online issue, any requests approved by the Editor will result in a corrigendum.
……
更多详情：
https://www.elsevier.com/journals/the-ocular-surface/1542-0124/guide-for-authors
